Interventional experiments using the SHH pathway activator (SAG) on MORF4L1-knockdown cells restored spheroid formation capacity and in vivo tumorigenicity, establishing MORF4L1’s pivotal role in HCC stemness through the Hedgehog pathway activation (Figs. 8E–J). The gene discussed is SHH; the disease is hepatocellular carcinoma.